SPY S&P futures skyrocket after Gilead (GILD) issues statement on data emerging from NIAID study of investigational antiviral remdesivir for the treatment of COVID-19; company understands that the trial has met its primary endpoint (see 8:31) (290.75 +4.96)
S&P futures higher by 47 points.
The following sectors were most impacted by the economic distributions and could see the largest rebound:
The S&P 500 materials (-3.0%) and financials (-2.7%) sectors lagged, while the consumer discretionary (+0.4%) and communication services (+0.02%) sectors eked out small gains. Notably, mega-cap technology stocks remained in favor, with Amazon (AMZN 2474.00, +101.29, +4.3%) and Apple (AAPL 293.95, +6.22, +2.2%) rallying in front of their earnings reports after the close. Facebook (FB 204.35, +10.16, +5.2%) and Microsoft (MSFT 179.13, +1.70, +1.0%) also finished higher following their earnings. Conversely, Tesla (TSLA 781.88, -18.63, -2.3%), McDonald's (MCD 187.56, -0.26, -0.1%), Comcast (CMCSA 37.63, -1.37, -3.5%), Twitter (TW
In U.S. Corporate news: Apple (AAPL 284.77, -9.03): -3.1% despite beating top and bottom-line estimates, increasing its dividend by 6% to $0.82/share, and increasing its share repurchase program by $50 billion. The company did not provide Q3 guidance. Amazon (AMZN 2328.01, -145.99): -5.9% after missing earnings estimates and guiding Q2 operating income below consensus. Visa (V 174.32, -4.40): -2.5% despite beating top and bottom-line estimates. Exxon Mobil (XOM 45.65, -0.82): -1.8% after missing top and bottom-line estimates. Chevron (CVX 91.20, -0.80): -0.9% despite beating revenue estimates.
SPY S&P futures skyrocket after Gilead (GILD) issues statement on data emerging from NIAID study of investigational antiviral remdesivir for the treatment of COVID-19; company understands that the trial has met its primary endpoint (see 8:31) (290.75 +4.96)
S&P futures higher by 47 points.
The following sectors were most impacted by the economic distributions and could see the largest rebound:
SPY S&P futures skyrocket after Gilead (GILD) issues statement on data emerging from NIAID study of investigational antiviral remdesivir for the treatment of COVID-19; company understands that the trial has met its primary endpoint (see 8:31) (290.75 +4.96)
S&P futures higher by 47 points.
The following sectors were most impacted by the economic distributions and could see the largest rebound:
SPY S&P futures skyrocket after Gilead (GILD) issues statement on data emerging from NIAID study of investigational antiviral remdesivir for the treatment of COVID-19; company understands that the trial has met its primary endpoint (see 8:31) (290.75 +4.96)
S&P futures higher by 47 points.
The following sectors were most impacted by the economic distributions and could see the largest rebound:
S&P futures higher by 47 points.
The following sectors were most impacted by the economic distributions and could see the largest rebound:
Restaurants: MCD, SBUX, CMG, YUM, DPZ, DRI, WEN, EAT, TXRH, PZZA, CBRL, JACK, CAKE, CHUY
Cruise Lines: CCL, RCL, NCLH
Airlines: AAL, ALGT, ALK, BA, DAL, HA, JBLU, LUV, SAVE, UAL
Hotels: CHH, DRH, H, IHG, MAR, SHO
Casinos: LVS, MGP, WYNN, VICI, MGM, MLCO, TSG, GLPI, CZR, BYD, PENN, MCRI
Event Planning: LYV
Ride Share companies: LYFT, UBER
Amusement Parks: SIX, FUN, DIS
Health Clubs: PLNT
有，这个礼拜每日新增都在下降，整体的growth rate也在下降。
正解，股票买的预期，最糟糕的情况已经过去了
还没来吧？美联储不是还在考虑要不要直接买股票么？
Indeed
如果形式大好，为啥FED还在考虑要不要直接买股票？
真牛啊
Apple (AAPL 284.77, -9.03): -3.1% despite beating top and bottom-line estimates, increasing its dividend by 6% to $0.82/share, and increasing its share repurchase program by $50 billion. The company did not provide Q3 guidance.
Amazon (AMZN 2328.01, -145.99): -5.9% after missing earnings estimates and guiding Q2 operating income below consensus.
Visa (V 174.32, -4.40): -2.5% despite beating top and bottom-line estimates.
Exxon Mobil (XOM 45.65, -0.82): -1.8% after missing top and bottom-line estimates.
Chevron (CVX 91.20, -0.80): -0.9% despite beating revenue estimates.
mark~~~~~~~~~~~~~~~~
感谢分享！
总结得很好，谢谢